131 results
Page 3 of 7
8-K
EX-99.1
6qtpjsksiq5xlv altzo
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
S-3ASR
e61fe vhnu
26 Feb 21
Automatic shelf registration
12:00am
S-3ASR
cgc2jt0n0667ls pr
26 Feb 21
Automatic shelf registration
12:00am
8-K
EX-99.1
15loccyf
17 Feb 21
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
4:09pm
8-K
EX-99.2
vtz4bu4j 89
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
8-K
EX-99.1
03i34m
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
ye8ba
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
98ybx
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.1
w21v9n1 aujgb5wrldi1
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.2
s5d2tb2e3y g1ezfqsor
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.2
jlbsf kvvhlkvh
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K
EX-99.1
88wea xzmqyzdui82ho
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
424B7
zf9af
5 Nov 20
Prospectus with selling stockholder info
5:27pm
8-K
EX-99.1
vs4db48 xvnw
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-99.1
vbb8q c1ihffig
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
4py5p8l5m2jslktj9 nq
28 Aug 20
Prospectus supplement
4:31pm